Identification of specific autoantigens in Sjögren's syndrome by SEREX

Immunology

Volumn 116, Issue 1, 2005, Pages 53-63

  Uchida, Kazuo ^a   Akita, Yoichi ^a   Matsuo, Keitaro ^c   Fujiwara, Shigeyoshi ^d   Nakagawa, Atsuko ^e   Kazaoka, Yoshiaki ^b   Hachiya, Hiroshi ^f   Naganawa, Yoshiyuki ^g   Oh Iwa, Ichiro ^d   Ohura, Kiyoshi ^h   Saga, Shinsuke ^b   Kawai, Tatsushi ^a   Matsumoto, Yoshinari ^b   Shimozato, Kazuo ^a   Kozaki, Ken Ichi ^h,i  

^a AICHI GAKUIN UNIVERSITY   (Japan)

^b AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

^d JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^e National Children Medical Center   (Japan)

^f Department of Cardiology   (Japan)

^g OGAKI MUNICIPAL HOSPITAL   (Japan)

^h OSAKA DENTAL UNIVERSITY   (Japan)

ⁱ TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

IFI16; KLHL12; KLHL7; SEREX; Sjogren's syndrome

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; BIOLOGICAL MARKER; PROTEIN IFI16; PROTEIN KLHL12; PROTEIN KLHL7; RECOMBINANT DNA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIGEN ANTIBODY REACTION; ANTIGEN EXPRESSION; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SALIVARY GLAND; SEROLOGY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; BLOTTING, NORTHERN; BLOTTING, WESTERN; FEMALE; GENE LIBRARY; HUMANS; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PHOSPHOPROTEINS; SALIVARY GLANDS; SJOGREN'S SYNDROME;

EID: 23944473367     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2005.02197.x     Document Type: Article

References (30)

1. Talal N. Sjögren's syndrome: historical overview and clinical spectrum of disease. Rheum Dis Clin North Am 1992; 18:507-15.
2. Pertovaara M, Pukkala E, Laippala P, Miettinen A, Pasternack AA. longitudinal cohort study of Finnish patients with primary Sjögren's syndrome: clinical, immunological, and epidemiological aspects. Ann Rheum Dis 2001; 60:467-72.
3. Jonsson R, Moen K, Vestrheim D, Szodoray P. Current issues in Sjögren's syndrome. Oral Dis 2002; 8:130-40.
4. Gordon T, Topfer F, Keech C, Reynolds P, Chen W, Rischmueller M, McCluskey J. How does autoimmunity to La and Ro initiate and spread? Autoimmunity 1994; 18:87-92.
5. Topfer F, Gordon T, McCluskey J. Intra- and intermolecular spreading of autoimmunity involving the nuclear self-antigens La (SS-B) and Ro (SS-A). Proc Natl Acad Sci USA 1995; 92:875-9.
6. Haneji N, Nakamura T, Takio K et al. Identification of alpha-fodrin as a candidate autoantigen in primary Sjogren's syndrome. Science 1997; 276:604-7.
7. Kuwana M, Okano T, Ogawa Y, Kaburaki J, Kawakami Y. Autoantibodies to the amino-terminal fragment of beta-fodrin expressed in glandular epithelial cells in patients with Sjögren's syndrome. J Immunol 2001; 167:5449-56.
8. Gordon TP, Bolstad AI, Rischmueller M, Jonsson R, Waterman SA. Autoantibodies in primary Sjögren's syndrome: new insights into mechanisms of autoantibody diversification and disease pathogenesis. Autoimmunity 2001; 34:123-32.
9. Bolstad AI, Jonsson R. Genetic aspects of Sjögren's syndrome. Arthritis Res 2002; 4:353-9.
10. Winer S, Astsaturov I, Cheung R et al. Primary Sjögren's syndrome and deficiency of ICA69. Lancet 2002; 360:1063-9.
11. Vitali C, Bombardieri S, Moutsopoulos M et al. Assessment of European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. Ann Rheum Dis 1996; 55:116-21.
12. Ohara T, Itoh Y, Itoh K. Reevaluation of laboratory parameters in relation to histological findings in primary and secondary Sjögren's syndrome. Intern Med 2000; 39:457-63.
13. Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61:554-8.
14. Sahin U, Tureci O, Schmitt H et al. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 1995; 92:11810-3.
15. Obata Y, Takahashi T, Tamaki H et al. Identification of cancer antigens in breast cancer by the SEREX expression cloning method. Breast Cancer 1999; 6:305-11.
16. Obata Y, Takahashi T, Sakamoto J, Tamaki H, Tominaga S, Hamajima N, Chen YT, Old LJ. SEREX analysis of gastric cancer antigens. Cancer Chemother Pharmacol 2000; 46:S37-42.
17. Frampton G, Moriya S, Pearson JD et al. Identification of candidate endothelial cell autoantigens in systemic lupus erythematosus using a molecular cloning strategy: a role for ribosomal P protein P0 as an endothelial cell autoantigen. Rheumatology 2000; 39:1114-20.
18. Kemp EH, Herd LM, Waterman EA, Wilson AG, Weetman AP, Watson PP. Immunoscreening of phage-displayed cDNA-encoded polypeptides identifies B cell targets in autoimmune disease. Biochem Biophys Res Commun 2002; 298:169-77.
19. Skoldberg F, Ronnblom L, Thornemo M, Lindahl A, Bird PI, Rorsman F, Kampe O, Landgren E. Identification of AHNAK as a novel autoantigen in systemic lupus erythematosus. Biochem Biophys Res Commun 2002; 291:951-8.
20. Lim Y, Lee DY, Lee S et al. Identification of autoantibodies associated with systemic lupus erythematosus. Biochem Biophys Res Commun 2002; 295:119-24.
21. Jeoung DI, Bong Lee E, Lee S, Lim Y, Lee DY, Kim J, Kim HY, Wook Song Y. Autoantibody to DNA binding protein B as a novel serologic marker in systemic sclerosis. Biochem Biophys Res Commun 2002; 299:549-54.
22. Choi YC, Chae CB. Demethylation of somatic and testis-specific histone H2A and H2B genes in F9 embryonal carcinoma cells. Mol Cell Biol 1993; 13:5538-48.
23. Tureci O, Sahin U, Zwick C, Koslowski M, Seitz G, Pfreundschuh M. Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens. Proc Natl Acad Sci USA 1998; 95:5211-6.
24. Bini P, Chu JL, Okolo C, Elkon K. Analysis of autoantibodies to recombinant La (SS-B) peptides in systemic lupus erythematosus and primary Sjögren's syndrome. J Clin Invest 1990; 85:325-33.
25. Trapani JA, Browne KA, Dawson MJ, Ramsay RG, Eddy RL, Show TB, White PC, Dupont B. A novel gene constitutively expressed in human lymphoid cells is inducible with interferon-gamma in myeloid cells. Immunogenetics 1992; 36:369-76.
26. Johnstone RW, Kershaw MH, Trapani JA. Isotypic variants of the interferon-inducible transcriptional repressor IFI 16 arise through differential mRNA splicing. Biochemistry 1998; 37:11924-31.
27. Waf1. J Biol Chem 2003; 278:40899-904.
28. Adams J, Kelso R, Cooley L. The kelch repeat superfamily of proteins: propellers of cell function. Trends Cell Biol 2000; 10:17-24.
29. Albagli O, Dhordain P, Deweindt C, Lecocq G, Leprince D. The BTB/POZ domain, a new protein-protein interaction motif common to DNA- and actin-binding proteins. Cell Growth Differ 1995; 6:1193-8.
30. Collins T, Stone JR, Williams AJ. All in the family, the BTB/POZ, KRAB, and SCAN domains. Mol Cell Biol 2001; 21:3609-15.